Elevated serum Bcl-2 in children with temporal lobe epilepsy.

Area of Science:

• Neuroscience
• Molecular Biology
• Pediatric Neurology

Background:

• Intractable temporal lobe epilepsy (TLE) involves changes in apoptosis-related signaling molecules within the temporal lobe.
• Bcl-2, an anti-apoptotic protein, has been previously observed at elevated levels in the brains and serum of TLE patients.

Purpose of the Study:

• To investigate serum Bcl-2 protein levels as a potential surrogate marker for apoptosis signaling in pediatric non-lesional TLE.
• To explore the relationship between serum Bcl-2 levels, seizure characteristics, and cognitive function in children with TLE.

Main Methods:

• Serum samples were collected from children diagnosed with non-lesional TLE and age-matched controls.
• Serum Bcl-2 protein levels were quantified using immunoassay techniques.
• Cognitive function was assessed using the total score intelligence quotient (IQ) test.

Main Results:

• Children with TLE exhibited significantly higher serum Bcl-2 levels compared to healthy controls.
• Elevated serum Bcl-2 levels positively correlated with disease duration, seizure frequency, and overall disease severity.
• Patients with TLE showed lower IQ scores than controls, and these scores were negatively correlated with serum Bcl-2 levels.

Conclusions:

• Serum Bcl-2 protein levels can serve as a valuable biomarker for assessing seizure burden in pediatric TLE.
• Serum Bcl-2 levels are associated with cognitive impairment in children suffering from TLE.
• These findings highlight the potential of serum Bcl-2 as a non-invasive indicator of disease activity and neurological impact in pediatric epilepsy.